Cited by 249Retinal Diseases and TreatmentsComplement system in diseasesOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Role of Complement and Complement Membrane Attack Complex in Laser-Induced Choroidal Neovascularization

Bora, Puran S, Sohn, Jeong-Hyeon, Cruz, Jose M C, Jha, Purushottam, Nishihori, Hiroki, Wang, Yali, Kaliappan, Sankaranarayanan, Kaplan, Henry J, Bora, Nalini S·2005·The Journal of Immunology

DOI 10.4049/jimmunol.174.1.491

Open this paper in CoChat — free account

Abstract

Choroidal neovascularization (CNV), or choroidal angiogenesis, is the hallmark of age-related macular degeneration and a leading cause of visual loss after age 55. The pathogenesis of new choroidal vessel formation is poorly understood. Although inflammation has been implicated in the development of CNV, the role of complement in CNV has not been explored experimentally. A reliable way to produce CNV in animals is to rupture Bruch’s membrane with laser photocoagulation. A murine model of laser-induced CNV in C57BL/6 mice revealed the deposition of C3 and membrane attack complex (MAC) in the neovascular complex. CNV was inhibited by complement depletion using cobra venom factor and did not develop in C3−/− mice. Anti-murine C6 Abs in C57BL/6 mice inhibited MAC formation and also resulted in the inhibition of CNV. Vascular endothelial growth factor, TGF-β2, and β-fibroblast growth factor were elevated in C57BL/6 mice after laser-induced CNV; complement depletion resulted in a marked reduction in the level of these angiogenic factors. Thus, activation of complement, specifically the formation of MAC, is essential for the development of laser- induced choroidal angiogenesis in mice. It is possible that a similar mechanism may be involved in the pathophysiology of other angiogenesis essential diseases.

Integrity signals

Registry

Crossref · 10.4049/jimmunol.174.1.491

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy
Ferris, F. L., Fine, S., & Hyman, L. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040031330019 · Cited by 1,109
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Risk factors for age-related macular degeneration
Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C. W., Klein, B. E. K., Hofman, A., Jensen, S., Wang, J. J., & de Jong, P. T. V. M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00580-7 · Cited by 1,071
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,029
Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748
The codependence of angiogenesis and chronic inflammation
Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 692
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice
Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B. C., Kuziel, W. A., Rollins, B. J., & Ambati, B. K. (2003) · Nature Medicine · doi:10.1038/nm950 · Cited by 631
Prevention of Experimental Choroidal Neovascularization With Intravitreal Anti–Vascular Endothelial Growth Factor Antibody Fragment
Krzystolik, M. G. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.3.338 · Cited by 591
The role of complement in inflammation and phagocytosis
Frank, M. M., & Fries, L. F. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90009-i · Cited by 505

Show all 48 references

Research works printed but not linked: 51

1984, Arch. Ophthalmol., 1640
2000, N. Engl. J. Med., 483
2000, J. Cell. Physiol., 301
1995, Ophthalmology, 1380
2001, Ophthalmology, 697
1991, Arch. Ophthalmol., 1109
2001, Prog. Retinal Eye Res., 227
1999, Mol. Vis., 26
2002, Drugs Aging, 101
2002, Ophthalmol. Clin. North Am., 87
2000, J. Med. Genet., 83
1997, FASEB J., 457
1994, Invest. Ophthalmol. Vis. Sci., 3874
2001, Prog. Retinal Eye Res., 385
1997, Graefes Arch. Clin. Exp. Ophthalmol., 313
1995, Proc. Natl. Acad. Sci. USA, 905
2003, Invest. Ophthalmol. Vis. Sci., 3578
2003, Invest. Ophthalmol. Vis. Sci., 3586
2003, Nat. Med., 1390
1980, Clinical Immunology, 219
1991, Immunol. Today, 322
1993, Curr. Opin. Immunol., 83
1992, Curr. Top. Microbiol. Immunol., 115
1993, J. Clin. Invest., 1974
1994, J. Exp. Med., 985
1999, Am. J. Pathol., 1701
1990, Invest. Ophthalmol. Vis. Sci., 899
1995, Invest. Ophthalmol. Vis. Sci., 2110
1999, Nat. Med., 292
2003, Proc. Natl. Acad. Sci. USA, 2679
2003, Nat. Med., 206
Invest. Ophthalmol. Vis. Sci., 3492
1961, Experimental Immunochemistry, 133
2001, Biochem. Pharm., 253
1999, Mol. Endocrinol., 806
1983, J. Exp. Med., 1885
2000, Proc. Natl. Acad. Sci. USA, 5450
2002, Invest. Opthalmol. Vis. Sci., 1104
1989, J. Immunol., 2654
1995, Proc. Natl. Acad. Sci. USA, 8955
1996, Proc. Natl. Acad. Sci. USA, 8563
1994, Invest. Opthalmol. Vis. Sci., 3178
1996, Curr. Eye Res., 1008
1996, Jpn. J. Ophthalmol., 329
1997, Curr. Eye Res., 9
2000, Invest. Ophthalmol. Vis. Sci., 3158
2002, Arch. Ophthalmol., 338
2000, Exp. Eye Res., 441
2000, FASEB J., 835
2002, Am. J. Ophthalmol., 411
1998, Arch. Ophthalmol., 1629

Sorted by citations

Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 784
Para-Inflammation in the Aging Retina
Xu, H., Chen, M., & Forrester, J. V. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.001 · Cited by 659
Drusen complement components C3a and C5a promote choroidal neovascularization
Nozaki, M., Raisler, B. J., Sakurai, E., Sarma, J. V., Barnum, S. R., Lambris, J. D., Chen, Y., Zhang, K., Ambati, B. K., Baffi, J. Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408835103 · Cited by 650
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
Girardi, G., Yarilin, D. A., Thurman, J. M., Holers, V. M., & Salmon, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061022 · Cited by 509
Angiogenesis and chronic inflammation: cause or consequence?
Costa, C., Incio, J., & Soares, R. A. (2007) · Angiogenesis · doi:10.1007/s10456-007-9074-0 · Cited by 510
Animal models of age related macular degeneration
Pennesi, M. E., Neuringer, M., & Courtney, R. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.003 · Cited by 391
“The role of the complement cascade in the formation of CNV has been demonstrated in the laser trauma model (Bora et al., 2005).”
Background
Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
Kim, S. J., Flach, A. J., & Jampol, L. M. (2010) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.07.005 · Cited by 388
Systemic Complement Activation in Age-Related Macular Degeneration
Scholl, H. P. N., Issa, P. C., Walier, M., Janzer, S., Pollok‐Kopp, B., Börncke, F., Fritsche, L. G., Chong, V. N., Fimmers, R., Wienker, T. F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002593 · Cited by 374
Animal models of choroidal and retinal neovascularization
Grossniklaus, H. E., Kang, S. J., & Berglin, L. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.05.003 · Cited by 350
Plasma complement components and activation fragments: Associations with age-related macular degeneration genotypes and phenotypes
Reynolds, R., Hartnett, M. E., Atkinson, J. P., Giclas, P. C., Rosner, B., & Seddon, J. M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3928 · Cited by 294
Age-Related Macular Degeneration Revisited – Piecing the Puzzle: The LXIX Edward Jackson Memorial Lecture
Miller, J. W. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.10.018 · Cited by 254
Cancer and the Complement Cascade
Rutkowski, M. J., Sughrue, M. E., Kane, A. J., Mills, S. A., & Parsa, A. T. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0225 · Cited by 253
Macular degeneration: recent advances and therapeutic opportunities
Rattner, A., & Nathans, J. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn2007 · Cited by 233
The Membrane Attack Complex in Aging Human Choriocapillaris
Mullins, R. F., Schoo, D. P., Sohn, E. H., Flamme‐Wiese, M. J., Workamelahu, G., Johnston, R. M., Wang, K., Tucker, B. A., & Stone, E. M. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.07.017 · Cited by 236
Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy
Zhang, S. X., & Ma, J. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.09.002 · Cited by 213
The Role of Complement in Tumor Growth
Pı́o, R., Corrales, L. P., & Lambris, J. D. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_11 · Cited by 199
Anatomy and development of the macula: specialisation and the vulnerability to macular degeneration
Provis, J. M., Penfold, P. L., Cornish, E. E., Sandercoe, T. M., & Madigan, M. C. (2005) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2005.tb06711.x · Cited by 206
Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury
Thurman, J. M., Renner, B., Kunchithapautham, K., Ferreira, V. P., Pangburn, M. K., Ablonczy, Z., Tomlinson, S., Holers, V. M., & Rohrer, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808166200 · Cited by 188
Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis
Langer, H. F., Chung, K.-J., Orlova, V. V., Choi, E. Y., Kaul, S., Kruhlak, M. J., Alatsatianos, M., DeAngelis, R. A., Roche, P. A., Magotti, P., et al. (2010) · Blood · doi:10.1182/blood-2010-01-261503 · Cited by 176
Age-related macular degeneration and the complement system
Khandhadia, S., Cipriani, V., Yates, J. R. W., & Lotery, A. J. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.019 · Cited by 174
Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population.
Souied, E. H., Leveziel, N., Richard, F., Dragon‐Durey, M., COSCAS, G. J., Soubrane, G., Benlian, P., & Frémeaux‐Bacchi, V. (2005) · PubMed · Cited by 168
The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration
Grisanti, S., & Tatar, O. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.002 · Cited by 163
Immunopathological aspects of age-related macular degeneration
Patel, M. M., & Chan, C. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0112-9 · Cited by 167
Complement factor H in AMD: Bridging genetic associations and pathobiology
Toomey, C. B., Johnson, L. V., & Rickman, C. B. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.09.001 · Cited by 162
A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration
Rohrer, B., Long, Q., Coughlin, B., Wilson, R. B., Huang, Y., Qiao, F., Tang, P. H., Kunchithapautham, K., Gilkeson, G. S., & Tomlinson, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2222 · Cited by 154
VEGF regulates local inhibitory complement proteins in the eye and kidney
Keir, L. S., Firth, R., Aponik, L., Feitelberg, D., Sakimoto, S., Aguilar, E., Welsh, G. I., Richards, A., Usui, Y., Satchell, S. C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86418 · Cited by 154
C1q as a unique player in angiogenesis with therapeutic implication in wound healing
Bossi, F., Tripodo, C., Rizzi, L., Bulla, R., Agostinis, C., Guarnotta, C., Munaut, C., Baldassarre, G., Papa, G., Zorzet, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311968111 · Cited by 161
Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration
Little, K., Llorián‐Salvador, M., Tang, M., Du, X., Marry, S., Chen, M., & Xu, H. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02033-7 · Cited by 155
Role of C3a Receptors, C5a Receptors, and Complement Protein C6 Deficiency in Collagen Antibody-Induced Arthritis in Mice
Banda, N. K., Hyatt, S., Antonioli, A. H., White, J. T., Glogowska, M. J., Takahashi, K., Merkel, T. J., Stahl, G. L., Mueller‐Ortiz, S. L., Wetsel, R. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102310 · Cited by 137
Age-related maculopathy – Linking aetiology and pathophysiological changes to the ischaemia hypothesis
Feigl, B. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.11.004 · Cited by 139
The role of complement system in ocular diseases including uveitis and macular degeneration
Jha, P., Bora, P. S., & Bora, N. S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.145 · Cited by 134
Self-citation
Complement inhibition in cancer therapy
Pı́o, R., Ajona, D., & Lambris, J. D. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.001 · Cited by 130
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: Role of factor B and factor H
Bora, N. S., Kaliappan, S., Jha, P., Xu, Q., Sohn, J.-H., Dhaulakhandi, D. B., Kaplan, H. J., & Bora, P. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1872 · Cited by 124
Self-citation
Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: implications for age-related macular degeneration
Ebrahem, Q., Renganathan, K., Sears, J., Vasanji, A., Gu, X., Lu, L., Salomon, R. G., Crabb, J. W., & Anand-Apte, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601552103 · Cited by 117
Fit for the Eye: Aptamers in Ocular Disorders
Drolet, D. W., Green, L. S., Gold, L., & Janjić, N. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0573 · Cited by 123
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
Skeie, J. M., Fingert, J. H., Russell, S. R., Stone, E. M., & Mullins, R. F. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5322 · Cited by 114
Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration
Lechner, J., Chen, M., Hogg, R. E., Tóth, L., Silvestri, G., Chakravarthy, U., & Xu, H. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0060-5 · Cited by 114
Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
Yeo, N. J. Y., Chan, E. J. J., & Cheung, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01363 · Cited by 120
Mouse models of age-related macular degeneration
Elizabeth Rakoczy, P., Yu, M. J. T., Nusinowitz, S., Chang, B., & Heckenlively, J. R. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.012 · Cited by 107
Amyloid‐β up‐regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age‐related macular degeneration
Wang, J., Ohno‐Matsui, K., Yoshida, T., Shimada, N., Ichinose, S., Sato, T., Mochizuki, M., & Morita, I. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21742 · Cited by 108
Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases
Wiley, L. A., Burnight, E. R., Songstad, A. E., Drack, A. V., Mullins, R. F., Stone, E. M., & Tucker, B. A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.10.002 · Cited by 109
Independent Effects of Complement Factor H Y402H Polymorphism and Cigarette Smoking on Risk of Age-Related Macular Degeneration
Scott, W. K., Schmidt, S., Hauser, M. A., Gallins, P. J., Schnetz‐Boutaud, N. C., Spencer, K. L., Gilbert, J. R., Agarwal, A., Postel, E. A., Haines, J. L., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.08.054 · Cited by 106
Retinal pigment epithelium in the pathogenesis of age‐related macular degeneration and photobiomodulation as a potential therapy?
Ao, J., Wood, J. P. M., Chidlow, G., Gillies, M. C., & Casson, R. J. (2017) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13121 · Cited by 104
Age-Related Macular Degeneration in the Aspect of Chronic Low-Grade Inflammation (Pathophysiological ParaInflammation)
Nita, M., Grzybowski, A. E., Ascaso, F. J., & Huerva, V. (2014) · Mediators of Inflammation · doi:10.1155/2014/930671 · Cited by 128
Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
Campa, C., Costagliola, C., Incorvaia, C., Sheridan, C., Semeraro, F., Nadai, K. D., Sebastiani, A., & Parmeggiani, F. (2010) · Mediators of Inflammation · doi:10.1155/2010/546826 · Cited by 97
A Systematic Investigation on Complement Pathway Activation in Diabetic Retinopathy
Hameed, S. S., Vishwakarma, S., Chhablani, J. K., Tyagi, M., Pappuru, R. R., Jakati, S., Chakrabarti, S., & Kaur, I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00154 · Cited by 95
Estimation of Systemic Complement C3 Activity in Age-Related Macular Degeneration
Sivaprasad, S. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.4.515 · Cited by 95
C5b-9-induced Endothelial Cell Proliferation and Migration Are Dependent on Akt Inactivation of Forkhead Transcription Factor FOXO1
Fosbrink, M. D., Niculescu, F. I., Rus, V., Shin, M. L., & Rus, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602055200 · Cited by 94
Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects
Danis, R. P., Lavine, J. A., & Domalpally, A. (2015) · Clinical ophthalmology · doi:10.2147/opth.s92359 · Cited by 100
CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration
Bora, N. S., Kaliappan, S., Jha, P., Xu, Q., Sivasankar, B., Harris, C. L., Morgan, B. P., & Bora, P. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1783 · Cited by 91
Self-citation
Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions
Kim, B. J., Mastellos, D. C., Li, Y., Dunaief, J. L., & Lambris, J. D. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100936 · Cited by 92
Autoimmunity in retinal degeneration: Autoimmune retinopathy and age-related macular degeneration
Morohoshi, K., Goodwin, A. M., Ohbayashi, M., & Ono, S. J. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.003 · Cited by 96
Targeting microglia for the treatment of Alzheimer’s disease
McGeer, P. L., & McGeer, E. G. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.988707 · Cited by 92
Gene–environment interactions in ocular diseases
Saccà, S. C., Bolognesi, C., Battistella, A., Bagnis, A., & Izzotti, A. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.002 · Cited by 84
Complement system and age-related macular degeneration: drugs and challenges
Wu, J., & Sun, X. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s206355 · Cited by 80
Functions of the complement components C3 and C5 during sepsis
Flierl, M. A., Rittirsch, D., Nadeau, B. A., Day, D. E., Zetoune, F. S., Sarma, J. V., Huber-Lang, M. S., & Ward, P. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-110595 · Cited by 81
Change in Drusen Volume as a Novel Clinical Trial Endpoint for the Study of Complement Inhibition in Age-related Macular Degeneration
Filho, C. A. D. A. G., Yehoshua, Z., Gregori, G., Nunes, R. P., Penha, F. M., Moshfeghi, A. A., Zhang, K., Feuer, W. J., & Rosenfeld, P. J. (2013) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20131217-01 · Cited by 79
Reliability of the Mouse Model of Choroidal Neovascularization Induced by Laser Photocoagulation
Poor, S. H., Qiu, Y., Fassbender, E. S., Shen, S., Woolfenden, A. E., Delpero, A. R., Kim, Y., Buchanan, N. M., Gebuhr, T. C., Hanks, S. M., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15067 · Cited by 73
The Complement System Plays a Critical Role in the Development of Experimental Autoimmune Anterior Uveitis
Jha, P., Sohn, J.-H., Xu, Q., Nishihori, H., Wang, Y., Nishihori, S., Manickam, B., Kaplan, H. J., Bora, P. S., & Bora, N. S. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1062 · Cited by 72
Self-citation
Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina
Vogt, S. D., Barnum, S. R., Curcio, C. A., & Read, R. W. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.04.002 · Cited by 71
Implications of genetic variation in the complement system in age-related macular degeneration
de Jong, S., Gagliardi, G., Garanto, A., de Breuk, A., Lechanteur, Y. T. E., Katti, S., van den Heuvel, L. P., Volokhina, E. B., & den Hollander, A. I. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100952 · Cited by 71
The Role of PGE 2 Receptor EP 4 in Pathologic Ocular Angiogenesis
Yanni, S. E., Barnett, J. M., Clark, M. L., & Penn, J. S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3652 · Cited by 73
Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment
Dhingra, N., Kelly, S., Majid, M., Bailey, C., & Dick, A. D. (2009) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.58467 · Cited by 69
Complement system activation and endothelial dysfunction in patients with age‐related macular degeneration (AMD): possible relationship between AMD and atherosclerosis
Machalińska, A., Kawa, M. P., Marlicz, W. M., & Machaliński, B. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02295.x · Cited by 69
The role of complement in ocular pathology
Bora, N. S., Jha, P., & Bora, P. S. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0110-y · Cited by 71
Self-citation
Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina.
Mullins, R. F., Skeie, J. M., Malone, E. A., & Kuehn, M. H. (2006) · PubMed · Cited by 66
Oxidative Stress Sensitizes Retinal Pigmented Epithelial (RPE) Cells to Complement-mediated Injury in a Natural Antibody-, Lectin Pathway-, and Phospholipid Epitope-dependent Manner
Joseph, K., Kulik, L. N., Coughlin, B. A., Kunchithapautham, K., Bandyopadhyay, M., Thiel, S., Thielens, N. M., Holers, V. M., & Rohrer, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421891 · Cited by 67
Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
Russo, A., Costagliola, C., Delcassi, L., Parmeggiani, F., Romano, M. R., dell’Omo, R., & Semeraro, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/476525 · Cited by 69
Polyethylene Glycol (PEG)-induced Mouse Model of Choroidal Neovascularization
Lyzogubov, V. V., Tytarenko, R. G., Liu, J., Bora, N. S., & Bora, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204701 · Cited by 64
Self-citation
The complement system and age-related macular degeneration
Sivaprasad, S., & Chong, V. N. (2006) · Eye · doi:10.1038/sj.eye.6702176 · Cited by 67
Complement System in Pathogenesis of AMD: Dual Player in Degeneration and Protection of Retinal Tissue
Kawa, M. P., Machalińska, A., Rogińska, D., & Machaliński, B. (2014) · Journal of Immunology Research · doi:10.1155/2014/483960 · Cited by 65
Ocular Angiogenesis: Vascular Endothelial Growth Factor and Other Factors
Rubio, R. G., & Adamis, A. P. (2015) · Developments in ophthalmology · doi:10.1159/000431129 · Cited by 62
Renoprotective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system
Chen, X., Delić, D., Cao, Y., Shen, L., Shao, Q., Zhang, Z., Wu, H., Hasan, A. A., Reichetzeder, C., Gaballa, M. M. S., et al. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00528.2022 · Cited by 61
Elevated Plasma Levels of C3a Complement Compound in the Exudative Form of Age-Related Macular Degeneration
Machalińska, A., Dziedziejko, V., Mozolewska‐Piotrowska, K., Karczewicz, D., Wiszniewska, B., & Machaliński, B. (2009) · Ophthalmic Research · doi:10.1159/000219686 · Cited by 62
Drugs in Phase II clinical trials for the treatment of age-related macular degeneration
Tolentino, M. J., Dennrick, A., John, E. S., & Tolentino, M. S. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.961601 · Cited by 60
Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor
Geisen, P., McColm, J. R., & Hartnett, M. E. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.08.021 · Cited by 59
Evidence for association between multiple complement pathway genes and AMD
Dinu, V., Miller, P. L., & Zhao, H. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20204 · Cited by 58
Therapeutic targeting of the complement system in age‐related macular degeneration: a review
Troutbeck, R., Al‐Qureshi, S., & Guymer, R. H. (2012) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02581.x · Cited by 60
Molecular response of chorioretinal endothelial cells to complement injury: Implications for macular degeneration
Zeng, S., Whitmore, S. S., Sohn, E. H., Riker, M. J., Wiley, L. A., Scheetz, T. E., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2016) · The Journal of Pathology · doi:10.1002/path.4669 · Cited by 56
A Two-Stage Laser-Induced Mouse Model of Subretinal Fibrosis Secondary to Choroidal Neovascularization
Little, K., Llorián‐Salvador, M., Tang, M., Du, X., O'Shaughnessy, Ó., McIlwaine, G., Chen, M., & Xu, H. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.4.3 · Cited by 56
Choroidal Neovascularization Enhanced by Chlamydia pneumoniae via Toll-like Receptor 2 in the Retinal Pigment Epithelium
Fujimoto, T. R., Sonoda, K., Hijioka, K., Sato, K., Takeda, A., Hasegawa, E., Oshima, Y., & Ishibashi, T. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4464 · Cited by 59
Complement regulation in the eye: implications for age-related macular degeneration
Wilke, G. A., & Apte, R. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178296 · Cited by 55
Matrix Metalloproteinase Activity Creates Pro-Angiogenic Environment in Primary Human Retinal Pigment Epithelial Cells Exposed to Complement
Bandyopadhyay, M., & Rohrer, B. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8638 · Cited by 59
Renal C3 Complement Component: Feed Forward to Diabetic Kidney Disease
Kelly, K. J., Liu, Y., Zhang, J., & Dominguez, J. H. (2015) · American Journal of Nephrology · doi:10.1159/000371426 · Cited by 54
Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice
Bora, N. S., Jha, P., Lyzogubov, V. V., Kaliappan, S., Liu, J., Tytarenko, R. G., Fraser, D. A., Morgan, B. P., & Bora, P. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.153130 · Cited by 53
Self-citation
The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets
Nording, H., Baron, L., Haberthür, D., Emschermann, F., Mezger, M., Sauter, M., Sauter, M., Patzelt, J., Knoepp, K., Nording, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23499-w · Cited by 53
New therapeutic targets in atrophic age-related macular degeneration
Petrukhin, K. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.625 · Cited by 53
Suppression of Complement Regulatory Proteins (CRPs) Exacerbates Experimental Autoimmune Anterior Uveitis (EAAU)
Jha, P., Sohn, J.-H., Xu, Q., Wang, Y., Kaplan, H. J., Bora, P. S., & Bora, N. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7221 · Cited by 52
Self-citation
Expression of Complement Component 3 (C3) from an Adenovirus Leads to Pathology in the Murine Retina
Cashman, S. M., Desai, A., Ramo, K., & Kumar‐Singh, R. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6002 · Cited by 55
Sparing of age-related macular degeneration in rheumatoid arthritis
McGeer, P. L., & Sibley, J. T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.003 · Cited by 51
Relationship between Complement Membrane Attack Complex, Chemokine (C-C Motif) Ligand 2 (CCL2) and Vascular Endothelial Growth Factor in Mouse Model of Laser-induced Choroidal Neovascularization
Liu, J., Jha, P., Lyzogubov, V. V., Tytarenko, R. G., Bora, N. S., & Bora, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226266 · Cited by 50
Self-citation
Relationship between the complement system, risk factors and prediction models in age-related macular degeneration
Bora, N. S., Matta, B., Lyzogubov, V. V., & Bora, P. S. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.07.012 · Cited by 49
Self-citation
Role of Ocular Complement Factor H in a Murine Model of Choroidal Neovascularization
Lyzogubov, V. V., Tytarenko, R. G., Jha, P., Liu, J., Bora, N. S., & Bora, P. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091168 · Cited by 50
Self-citation
The Effect of Complement Factor H Y402H Polymorphism on the Outcome of Photodynamic Therapy in Age-related Macular Degeneration
Seitsonen, S. P., Järvelä, I. E., Meri, S., Tommila, P. V., Ranta, P. H., & Immonen, I. J. (2007) · European Journal of Ophthalmology · doi:10.1177/112067210701700612 · Cited by 48
The Complement Regulatory Protein CD46 Deficient Mouse Spontaneously Develops Dry-Type Age-Related Macular Degeneration–Like Phenotype
Lyzogubov, V. V., Bora, P. S., Wu, X., Horn, L. E., de Roque, R., Rudolf, X. V., Atkinson, J. P., & Bora, N. S. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.03.021 · Cited by 45
Self-citation
Novel biological networks modulated by complement
Mastellos, D. C., Andronis, C., Persidis, A., & Lambris, J. D. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.03.012 · Cited by 48
Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System
Borucki, D. M., Toutonji, A., Couch, C., Mallah, K., Rohrer, B., & Tomlinson, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.566892 · Cited by 46
C9-R95X Polymorphism in Patients with Neovascular Age-Related Macular Degeneration
Nishiguchi, K. M., Yasuma, T. R., Tomida, D., Nakamura, M., Ishikawa, K., Kikuchi, M., Ohmi, Y., Niwa, T., Hamajima, N., Furukawa, K., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8425 · Cited by 47
Differences in the temporal expression of regulatory growth factors during choroidal neovascular development
Hu, W., Criswell, M. H., Fong, S., Temm, C. J., Gangaraju, R., Cornell, T. L., & Clauss, M. A. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.10.014 · Cited by 46
Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration
Hammadi, S., Tzoumas, N., Ferrara, M., Meschede, I. P., Lo, K., Harris, C., Lako, M., & Steel, D. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082870 · Cited by 44

Authors: Bora, P. S., Sohn, J.-H., Cruz, J. M. C., Jha, P., Nishihori, H., Wang, Y., Kaliappan, S., Kaplan, H. J., & Bora, N. S.
Affiliations: University of Louisville (US)
ORCID: Bora, Puran S
Wang, Yali
Kaplan, Henry J
Venue: The Journal of Immunology
Publisher: Oxford University Press (OUP)
Published: 2005-01-01
Volume: 174
Issue: 1
Pages: 491-497
ISSN: 0022-1767 (ISSN-L)
1550-6606
DOI: 10.4049/jimmunol.174.1.491
OpenAlex: W1901360874
Cited by: 249
References: 48
Citations by year: 2026: 3 · 2025: 4 · 2024: 10 · 2023: 9 · 2022: 6 · 2021: 11 · 2020: 13 · 2019: 6 · 2018: 7 · 2017: 11 · 2016: 6 · 2015: 13 · 2014: 15 · 2013: 8 · 2012: 15
FWCI: 18.34
Type: journal article
Language: en
Open access: closed
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: The Journal of Immunology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (7r01ey009730-07)
National Eye Institute (R01 EY009730-07, R01EY013335, R01EY014623, EY 014623, EY-13335)
Topics: Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords: choroidal neovascularization, complement system, membrane attack complex, choroidal angiogenesis, age-related macular degeneration, laser photocoagulation, Bruch's membrane rupture, complement C3, complement depletion, cobra venom factor, vascular endothelial growth factor, TGF-beta2, basic fibroblast growth factor, angiogenic factors, mouse model
MeSH terms: Animals, Choroid, Complement Activation, Complement C3, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Fibroblast Growth Factors, Immunohistochemistry, Lasers, Male, Complement Membrane Attack Complex, Transforming Growth Factor beta, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, Choroidal Neovascularization, Vascular Endothelial Growth Factor A, Mice, Transforming Growth Factor beta2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of Complement and Complement Membrane Attack Complex in Laser-Induced Choroidal Neovascularization

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks